PROSPECTIVE STUDY ON THE EXPRESSION OF IRREGULAR ERYTHROCYTE ANTIBODIES AFTER TRANSFUSION-A PILOT STUDY-
Author:
Affiliation:
1. Transfusion and Cell Therapy, Hamamatsu University School of Medicine
Publisher
Japan Society of Transfusion Medicine and Cell Therapy
Subject
Computer Networks and Communications,Hardware and Architecture,Software
Link
https://www.jstage.jst.go.jp/article/jjtc/65/5/65_810/_pdf
Reference23 articles.
1. 1) Mo Z, Li H, Huang L, et al: Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi. Transfus Med, 25: 313-319, 2015.
2. Incidence of Irregular Red cell Antibodies at Kyushu University Hospital. 10-Year Study.
3. 3) Karafin MS, Westlake M, Hauser RG, et al: Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database. Br J Haematol, 181: 672-681, 2018.
4. 4) Zalpuri S, Zwaginga JJ, le Cessie S, et al: Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Vox Sang, 102: 144-149, 2012.
5. 5) Takeshita A, Watanabe H, Fujihara H, et al: Collaborative study of irregular erythrocyte antibodies in Japan: results from the Japanese study group of allo-immunity and antigen diversity in Asian populations. Transfus Apher Sci, 43: 3-8, 2010.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3